MEDICAL SCIENCE MONITOR-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2022-09-03 望洋兴叹0

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：医学
经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。

80 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2023-06-26 ms6000001069925438 来自台湾省

审稿速度:2.0
经验分享：Awaiting⊙▽⊙desion20多天了

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2022-05-17 ms9000000913432311

请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？

64 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2023-05-18 ms7000000865333902 来自重庆

awaiting decision一个多月了，有没有相同遭遇的战友

16 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2023-06-14 ms6000001069925438 来自宁夏

审稿速度:2.0
偏重的研究方向：医学
经验分享：awaiting decision一个周了，有没有相同遭遇的战友

28 0

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2023-06-01 ms6000001069925438 来自陕西省

偏重的研究方向：医学
经验分享：2023-05-30
Evaluation requests sent to reviewers
2023-05-08
Review pending
2023-04-26
Evaluation requests sent to reviewers
2023-04-25
Scientific triage completed
2023-04-25
In scientific triage
2023-04-25
Manuscript accepted for processing
2023-04-25
Plagiarism check (submission) 1 ready
2023-04-25
Sent for anti-plagiarism verification
2023-04-25
Submissions Approved
2023-04-24
Submission Received
什么情况呀？

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2023-05-16 ms7000000865333902 来自重庆

Awaiting⊙▽⊙desion差不多一个月了，是啥情

32 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2022-03-01 M026

已经三次“Review pending”了，大家也是这样的情况吗？

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2023-04-23 ms3000000725740513 来自河北省

不给理由的拒稿，外审了，也不给外审的意见，慎投

27 0

[GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：一篇综述，从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见，有个六七条重复的，算大修吧，段落有调整，增加了部分内容和两个表格。逐条修改并回应审稿人，没用二次修改。共三次查重，投之前自己查了，修稿后自己也查了，所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144763, encodeId=9a6c2144e6340, content=审稿速度:2.0 经验分享：Awaiting⊙▽⊙desion20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Mon Jun 26 09:47:38 CST 2023, time=2023-06-26, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=1220236, encodeId=7dd11220236a6, content=请问一下一般awaiting decesion 多久？我已经这个状态10多天了急啊是不是要被拒？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Tue May 17 10:20:04 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137718, encodeId=b334213e7180b, content=awaiting decision一个多月了，有没有相同遭遇的战友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Thu May 18 20:03:11 CST 2023, time=2023-05-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2142750, encodeId=762d2142e5054, content=审稿速度:2.0 偏重的研究方向：医学 经验分享：awaiting decision一个周了，有没有相同遭遇的战友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Wed Jun 14 14:51:45 CST 2023, time=2023-06-14, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2140295, encodeId=b0bd21402958e, content=偏重的研究方向：医学 经验分享：2023-05-30 Evaluation requests sent to reviewers 2023-05-08 Review pending 2023-04-26 Evaluation requests sent to reviewers 2023-04-25 Scientific triage completed 2023-04-25 In scientific triage 2023-04-25 Manuscript accepted for processing 2023-04-25 Plagiarism check (submission) 1 ready 2023-04-25 Sent for anti-plagiarism verification 2023-04-25 Submissions Approved 2023-04-24 Submission Received 什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19058496493, createdName=ms6000001069925438, createdTime=Thu Jun 01 11:10:33 CST 2023, time=2023-06-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2135586, encodeId=1e4821355868a, content=Awaiting⊙▽⊙desion差不多一个月了，是啥情 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75f8300368, createdName=ms7000000865333902, createdTime=Tue May 16 19:10:16 CST 2023, time=2023-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198521, encodeId=29f711985216f, content=已经三次“Review pending”了，大家也是这样的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ed45564759, createdName=M026, createdTime=Tue Mar 01 23:07:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127900, encodeId=e35a212e90036, content=不给理由的拒稿，外审了，也不给外审的意见，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31c5632601, createdName=ms3000000725740513, createdTime=Sun Apr 23 21:11:29 CST 2023, time=2023-04-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1215607, encodeId=9216121560e8d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？ 我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。 2022-04-28 In Copyediting 2022-04-28 Paid 2022-04-27 Accepted - invoice issued 2022-04-27 1st Post-Rev plagiarism check ready 2022-04-27 Sent for 1st Post-Rev antiplagiarism check 2022-04-27 Ready for Post-Rev antiplagiarism check 2022-04-27 Unlocked Note: Personal review recived 2022-04-12 Review 2 pending 2022-04-11 Review 2 requests sent to reviewers 2022-04-10 Unlocked Note: Deadline expired 2022-04-08 After authors corrections 2022-03-10 On hold Note: the authors need additional time for corrections 2022-03-03 Sent to author(s) for corrections (2 weeks) 2022-03-03 Reconsider after revision 2022-03-02 Awaiting decision 2022-03-02 2nd Scientific Triage Completed 2022-03-02 In 2nd Scientific triage 2022-02-14 Review pending 2022-01-17 Unlocked 2022-01-13 Evaluation requests sent to reviewers 2022-01-12 Scientific triage completed 2022-01-12 On hold Note: Waiting for IRB / IACUC 2022-01-12 In scientific triage 2022-01-12 Manuscript accepted for processing 2022-01-12 Plagiarism check (submission) 1 ready 2022-01-12 Sent for anti-plagiarism verification 2022-01-12 Submissions Approved 2022-01-11 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4542077825, createdName=linqn, createdTime=Fri Apr 29 15:16:40 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

2022-04-29 linqn

审稿速度:3.0 | 投稿命中率:50.0
经验分享：不知道为什么，中国人发的特别多，难道因为这个被中科院预警？
我感觉审稿人很专业很负责的，因为我写的比较乱，但审稿人看到混乱的结果和讨论背后有一些可靠的想法，才给了修回机会。
2022-04-28
In Copyediting
2022-04-28
Paid
2022-04-27
Accepted - invoice issued
2022-04-27
1st Post-Rev plagiarism check ready
2022-04-27
Sent for 1st Post-Rev antiplagiarism check
2022-04-27
Ready for Post-Rev antiplagiarism check
2022-04-27
Unlocked
Note: Personal review recived
2022-04-12
Review 2 pending
2022-04-11
Review 2 requests sent to reviewers
2022-04-10
Unlocked
Note: Deadline expired
2022-04-08
After authors corrections
2022-03-10
On hold
Note: the authors need additional time for corrections
2022-03-03
Sent to author(s) for corrections (2 weeks)
2022-03-03
Reconsider after revision
2022-03-02
Awaiting decision
2022-03-02
2nd Scientific Triage Completed
2022-03-02
In 2nd Scientific triage
2022-02-14
Review pending
2022-01-17
Unlocked
2022-01-13
Evaluation requests sent to reviewers
2022-01-12
Scientific triage completed
2022-01-12
On hold
Note: Waiting for IRB / IACUC
2022-01-12
In scientific triage
2022-01-12
Manuscript accepted for processing
2022-01-12
Plagiarism check (submission) 1 ready
2022-01-12
Sent for anti-plagiarism verification
2022-01-12
Submissions Approved
2022-01-11
Submission Received

70 10

展开10条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务